 CymaBay Therapeutics, Inc. NASDAQ:CBAY Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Paul Quinlan - General Counsel Sujal Shah - Chief Executive Officer Chuck McWherter - Chief Scientific Officer and President, RD Dennis Kim - Chief Medical Officer Lewis Stuart - Chief Commercial Officer Dan Menold - Vice President, Finance Conference Call Participants Steven Seedhouse - Raymond James Kristen Kluska - Cantor Fitzgerald Patrick Dolezal - LifeSci Capital Ed Arce - H.C. Wainwright Co Mayank Mamtani - B. 